Global Arrhythmia Market Projected to Grow at 8.9% CAGR, Reaching $11.65 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Arrhythmia Industry Market Size Be by 2025?
There has been robust growth in the arrhythmia market size in the last few years. The market, currently valued at $7.8 billion in 2024, is expected to escalate to $8.28 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.2%. Elements contributing to this historical growth include the rise in lifestyle-related risk factors, an increase in cardiovascular diseases, advancements in implantable devices, a global surge in cardiac surgeries, higher demand for remote monitoring, and ongoing research and development in antiarrhythmic drugs.

What's the Long-Term Growth Forecast for the Arrhythmia Market Size Through 2029?
The arrhythmia market is anticipated to witness robust growth in the upcoming years, reaching $11.65 billion by 2029 with a CAGR of 8.9%. This projected growth can be attributed to factors such as increased awareness and education, adoption of personalized healthcare, expansion of electrophysiology labs, emphasis on early detection and prevention, genetic testing for familial arrhythmias, and improvements in the healthcare infrastructure. Throughout the forecast period, significant trends include advancements in cardiac monitoring technologies, the utilization of telehealth and remote patient monitoring, an emphasis on the detection and management of atrial fibrillation (AF), the use of implantable devices for arrhythmia control, innovations in ECG monitoring devices, and a regulatory focus on medical device approvals.

View the full report here:
https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

What Are the Key Growth Drivers Fueling the Arrhythmia Market Expansion?
The increasing occurrence of cardiac disease and other heart-related issues is anticipated to fuel the expansion of the arrhythmia market. Cardiac or cardiovascular disease encompasses a variety of heart and blood vessel disorders, like atherosclerosis, heart attack, stroke, and arrhythmia, among others. Both functional impairments - such as diastolic and systolic dysfunction - and electrical disturbances leading to arrhythmias can lead to a high incidence of heart failure, atrial fibrillation, and other cardiovascular diseases. For example, the CDC (Centers for Disease Control and Prevention), a US government agency, reported in October 2022 that there were approximately 69.7k heart disease-related deaths and 80.5k heart attacks annually in the United States. Consequently, the rising occurrence of cardiac disease and other heart-related conditions is a major factor propelling the arrhythmia market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp

What Long-Term Trends Will Define the Future of the Arrhythmia Market?
The development of new treatment methods is a notable trend within the arrhythmia sector. Leading companies in the market are striving towards innovating new therapies such as cryoablation therapy, a novel treatment for arrhythmia patients. For example, US medical technology firm, GE HealthCare, introduced CardioVisio for Atrial Fibrillation in August 2023. This digital and patient-focused clinical decision support tool is designed for precision care, using rich data analytics and insightful patient information to aid healthcare professionals in grasping and controlling atrial fibrillation, a prevalent heart disorder. By providing customized care plans and tracking data in real time, CardioVisio aspires to heighten the precision of treatment decisions and uplift patient results, which stands as a substantial progress in the field of heart care management.

How Is the Arrhythmia Market Segmented?
The arrhythmia market covered in this report is segmented -

1) By Type: Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types
2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor
3) By Hearth Blocks: First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Supraventricular Tachycardias: Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT)
2) By Ventricular Arrhythmias: Ventricular Fibrillation, Ventricular Tachycardia, Premature Ventricular Contractions (PVCs)
3) By Bradyarrhythmias: Sinus Bradycardia, Heart Block
4) By Other Types: Long QT Syndrome, Wolff-Parkinson-White Syndrome, Torsades de Pointes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8018&type=smp

Which Companies Are Leading the Charge in Arrhythmia Market Innovation?
Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA

Which Regions Are Leading the Global Arrhythmia Market in Revenue?
North America was the largest region in the arrhythmia market in 2024. The regions covered in the arrhythmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8018

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.